ClariPeptideRetatrutide
Ordered Retatrutide from ClariPeptide? Mail in a sample (US only) and let us test it.
Test my supplyClariPeptide's Retatrutide signal is mixed because the newest tested vial was 100% pure but +71% overfilled, outside this purity-focus method's fill band. The earlier 99.9%/-13% result helps, but evidence is sparse and volatile.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including ClariPeptide rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 20 Oct 2026 | Fail | gq6t4xg Tested | lab name | View COA | |||
| 15 Sep 2026 | Pass | vdgf8sq Tested | lab name | View COA | |||
About ClariPeptide test results from Finnrick
ClariPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 2 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible ClariPeptide peptides in this dataset are Retatrutide (2 tests), BPC-157 (0 tests) and Cagrilintide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 2 recent tests.
Ordered Retatrutide from ClariPeptide? Mail in a sample (US only) and let us test it.
Test my supply